Priority Date: 01.06.12 (US 201261654235P)

METHODS RELATED TO RITUXIMAB

  • Application ID: EP13796989
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and C40 (COMBINATORIAL TECHNOLOGY) is specialized in the combination C12 and C40. There is no patent agent firm in the market, which is specialized in this combination of IPC classes.

Timeline

  • 01.06.2012 - Priority Date (US 201261654235P)
  • 05.12.2013 - Publication A2 (WO2013181599)
  • 08.04.2015 - Publication A2 (EP2856158)

IPC Classification